Kyoto University researchers have regenerated neural stem cells in an adult mouse and improved its cognitive function through its method, dubbed "iPaD."
The test results were equivalent to turning a 60-year-old-human's neural stem cells into those of a teenager.
However, there are challenges in applying the procedure to humans because the mouse’s genetic engineering involved using a virus to inject the genes into the brain.
The research team’s leader, visiting professor Ryoichiro Kageyama, said they would continue to see if the procedure can be applied to humans.
The team will now test its iPaD method on marmosets to determine if its applicability to primates.
The ability to multiply embryonic neural stem cells to increase the number of nerve cells weakens with age. That, in turn, results in reduced cognitive function.
The iPaD method maximizes the activation of the neural stem cells by combining the infant mice’s most active genes with a restraining function of the adult mice’s most active genes.
The engineered neural stem cells in an adult mouse became more active with the neural stem cells continuing to multiply for about three months.
|Consequently, the adult mouse improved its cognitive function with the increase in neural stem cell multiplication.


Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 



